Lanoxin Pg (Digoxin)

Digoxin inhibits the Na⁺/K⁺‑ATPase pump on cardiac cells, causing an increase in intracellular sodium. This change reduces the activity of the sodium‑calcium exchanger, leading to higher calcium levels inside the heart muscle, which strengthens each contraction. It also increases vagal tone, slowing conduction through the atrioventricular node and reducing heart rate.

The appropriate dose of Lanoxin Pg is individualized and must be determined by a qualified prescriber. Dosage depends on factors such as the patient’s age, renal function, electrolyte status, and response to therapy. Physicians typically start with a low dose and adjust based on clinical response and serum digoxin levels.

Safety data for digoxin in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the Lanoxin Pg product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Digoxin belongs to the cardiac glycoside class and primarily provides a positive inotropic effect and rate control, whereas many modern heart‑failure drugs (e.g., ACE inhibitors, beta‑blockers, ARNI) act by neurohormonal modulation. Digoxin is often added when patients remain symptomatic despite guideline‑directed therapy, but it requires careful monitoring for toxicity, unlike many newer agents.

Lanoxin Pg tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources, and discard any tablets that appear discolored or damaged.

Lanoxin Pg is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water. Patients should follow the exact dosing schedule provided and avoid crushing or chewing the tablet unless specifically instructed by a healthcare professional.

The most serious risks include cardiac arrhythmias such as ventricular tachycardia or severe bradycardia, which can be life‑threatening. Other critical concerns are hyperkalemia, especially in patients with renal impairment, and signs of digoxin toxicity like nausea, visual changes (yellow‑green halos), and confusion. Prompt medical attention is required if any of these symptoms occur.

Lanoxin Pg should be avoided in patients with known hypersensitivity to digoxin or other cardiac glycosides, in those with uncontrolled ventricular arrhythmias, and in individuals with severe renal failure without dose adjustment. Caution is also advised for patients taking interacting medications such as amiodarone or quinidine, and for pregnant or breastfeeding women unless the benefit clearly outweighs the risk.